首页 | 本学科首页   官方微博 | 高级检索  
检索        

A型肉毒毒素治疗口下颌肌张力障碍
引用本文:卫华,王玉平,陈海,孙莹,李莉萍,邢华芳.A型肉毒毒素治疗口下颌肌张力障碍[J].脑与神经疾病杂志,2010,18(5).
作者姓名:卫华  王玉平  陈海  孙莹  李莉萍  邢华芳
作者单位:首都医科大学宣武医院神经内科,北京,100053
摘    要:目的观察A型肉毒毒素治疗口下颌肌张力障碍(OMD)患者的临床效果。方法对19例口下颌肌张力障碍患者进行临床分析,依据患者临床特点,将A型肉毒毒素注射到患者一侧或双侧咀嚼肌、颞肌及翼外肌,并根据肌肉收缩力量大小、肌肉体积及患者体重调整剂量。结果 68.4%的患者功能改善评分≥3分,疗效平均维持8~12周(有效范围2~28周)。4例患者注射后有轻度咀嚼无力,2~3周恢复。1例混合型患者注射后出现轻度鼻音,持续13天后症状消失。所有患者未出现其它严重副作用。结论 A型肉毒毒素对于口下颌肌张力障碍的治疗是有效、安全的。熟悉本病的临床特点及分型,选择正确的靶肌肉及注射适宜剂量的肉毒毒素是治疗本病的关键。

关 键 词:口下颌肌张力障碍  肉毒毒素  闭口型肌张力障碍

Chinese botulinum toxin type A treatment in oromandibular dystonia
WEI Hua,WANG Yu-ping,CHEN Hai,SUN Ying,LI Li-ping,XING Hua-fang.Chinese botulinum toxin type A treatment in oromandibular dystonia[J].Journal of Brain and Nervous Diseases,2010,18(5).
Authors:WEI Hua  WANG Yu-ping  CHEN Hai  SUN Ying  LI Li-ping  XING Hua-fang
Institution:WEI Hua; WANG Yu-ping; CHEN Hai; SUN Ying; LI Li-ping; XING Hua-fang.Department of Neurology; Xuanwu Hospital; Capital Medical University; Beijing 100053; China;
Abstract:Objective To study different clinical manifestations of oromandibular dystonia(OMD)patients and the therapeutic efficacy of Chinese botulinum toxin type A(CBTX-A)in OMD patients.Methods This report described 19 patients with jaw-closing dystonia and mixed movement treated by injection of Chinese botulinum toxin type A(CBTX-A).Fourteen jaw-closing patients showed jaw clench,the other 5 mixed OMD patients showed jaw clench companied with its deviation to one side.CBTX-A was injected bilaterally or unilaterall...
Keywords:Oromandibular dystonia  Botulinum toxin  Jaw-closing dystonia
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号